Search for Novo Nordisk AS and
    1. September 14, 2014

      Novo Nordisk says US more open to obesity drugs

      US regulators are becoming more open to drugs for tackling obesity, says the chief executive of Novo Nordisk, as the Danish...

    2. May 1, 2014

      Novo Nordisk ends streak of double-digit quarterly growth

      Novo Nordisk failed to post quarterly double-digit sales growth for the first time in 12 years, bringing to an end one of...

    Special Reports

    1. Combating Diabetes

      With the number of cases predicted to reach 592m worldwide by 2013, tackling the condi...
    Search more Special Reports on this topic.

    1. April 1, 2014

      Bristol-Myers Squibb: side effects

      One of these things is not like the others, as Big Bird sings. Look at the mega-cap pharma and biotech stocks. In the near...

    2. March 27, 2014

      Baxter: own devices

      Once you’ve played the trump card, what do you do with the rest of your hand? That’s a question Baxter International’s...

    3. March 27, 2014

      Novo Nordisk joins fight against diabetes epidemic in cities

      Novo Nordisk is to team up with some of the world’s biggest cities to find ways of tackling diabetes, amid warnings that the...

    4. January 3, 2014

      Buy China and Scandinavia, sell France and Turkey

      Like almost everyone else, I’m cautiously optimistic about prospects for 2014. I think we’re in the fairly early stages of a...

    5. December 10, 2013

      Novo Nordisk reported to police over disclosure delay on ruling

      Novo Nordisk has been reported to the police by the Danish Financial Supervisory Authority for failing to disclose critical...

    6. November 14, 2013

      Drug manufacturers seek to expand the range of treatments

      Three companies have long dominated the commercial battle over insulin. For nearly a century since it was first developed,...

    7. November 14, 2013

      Diabetes sufferers seek injection of effort

      When Paul Zimmet first conducted research on the island of Nauru nearly four decades ago, he was shocked to find that a...

    8. November 14, 2013

      Universal availability of insulin yet to be achieved

      There are fewer than nine years to go before the centenary of insulin’s introduction in 1922, but David Beran is not ready...

    9. November 7, 2013

      Novo Nordisk faces headwinds to remain biggest Nordic group

      What is the biggest company in the Nordic region? Measured by market capitalisation, it is not AP Møller-Maersk or Ericsson,...

    10. August 22, 2013

      Eli Lilly drawn into pharmaceutical corruption claims in China

      Eli Lilly became the latest western pharmaceutical group to be drawn into escalating allegations of corruption in China,...

    11. August 11, 2013

      Comparing drug prices across borders a difficult task

      Comparing the prices of medicines across borders is an intellectual challenge for academics, a profitable business for...

    12. August 8, 2013

      Novo Nordisk raises forecasts amid demand for diabetes treatments

      Novo Nordisk, the Nordic region’s most valuable company by market capitalisation, raised its sales and profit guidance for...

    13. August 8, 2013

      Chinese drugs industry inquiry widens

      Three more western pharmaceutical companies have been drawn into widening Chinese probes into pricing and marketing...

    14. July 18, 2013

      Belgian pharma group in China probe

      UCB has become the latest focus of inquiries by Chinese officials in a growing clampdown on drug pricing and marketing...

    15. May 1, 2013

      Novo Nordisk/Lundbeck: drugs start working

      The news from Denmark’s sizeable pharmaceuticals sector has been suitably Nordic noir recently. H Lundbeck, beset by patent...

    16. April 15, 2013

      Healthcare bucks sell-off in Europe

      Heathcare was the most sought after sector on Monday amid a wider sell-off on global growth concerns that led to European...

    17. February 15, 2013

      Renault drives on from dire 2012

      Renault convinced investors this week that it had turned a corner after a dire 2012. The French carmaker said it had a net...

    18. February 11, 2013

      Novo Nordisk ails after drug ruling

      News that Novo Nordisk , the Danish drugs company, failed to win approval for a new drug triggered a strong response from...

    19. February 11, 2013

      Novo Nordisk: reality check

      There goes the visibility premium. Novo Nordisk has stood out from rivals in recent years because its growth has been so...

    20. February 11, 2013

      FDA rejects Novo Nordisk insulin remedy

      Novo Nordisk lost DKr80bn from its stock market value after the Danish drugs company failed to win US regulatory approval...

    21. January 8, 2013

      Novo Nordisk rises amid Denmark high

      Denmark’s index of leading blue-chip companies reached an all-time high on Tuesday. Copenhagen’s OMX 20 climbed 0.8 per cent...

    22. December 26, 2012

      Pharma groups hope for diet drugs binge

      As Christmas overeating gives way to under-fulfilled new year diets, the pharmaceutical industry’s appetite has been whetted...

    23. November 18, 2012

      Novo Nordisk becomes largest Nordic group

      Novo Nordisk has become the largest company in the Nordic region by market capitalisation, overtaking Norway’s Statoil,...

    24. November 16, 2012

      SAS survival hangs on crew pay deal

      The future of SAS is hanging in the balance after management issued an ultimatum this week to force pilots and cabin crew to...

    25. November 9, 2012

      Banks drive European equities lower

      Crédit Agricole capped a difficult week for European banks on Friday as the French lender reported a wider than expected net...

    26. October 31, 2012

      Novo Nordisk raises profit guidance

      Novo Nordisk has become one of the rare European companies to raise its profit guidance for the year, as the Danish drugs...

    27. October 4, 2012

      France’s bruiser disrupts Sanofi’s recovery

      The French language does not, I think, contain a verb that means “to mug a well-known company”. How about montebourger?...

    28. July 1, 2012

      BMS / Amylin

      Bad habits equal big opportunities. As the world’s population gets fatter, diabetes is on the rise. The World Health...

    29. March 28, 2012

      Amylin jumps 50% on talk of failed bid

      Shares in Amylin Pharmaceuticals rose more than 50 per cent on Wednesday on reports of a spurned $3.5bn takeover bid for the...

    30. February 5, 2012

      Pharma seeks to ease pain of euro crisis

      With Greece and Spain struggling to repay billions of euros in outstanding debts to the healthcare sector as the eurozone...

    31. January 22, 2012

      Food groups angry at obesity campaign

      Graphic marketing campaigns intended to frighten people about obesity are drawing fire from US beverage and restaurant...

    32. beyondbrics

      December 6, 2011

      Merck bets big on China

      For all the news of growth slowdowns, drug companies still love EMs. Merck, the US pharmaceutical giant, announced on...

    33. December 5, 2011

      A model for healthier profits

      When Poul Rasmussen is asked to justify the unusual governance structure of Leo Pharma, the Danish pharmaceutical group, he...

    34. beyondbrics

      December 5, 2011

      Pharma still bullish on EMs

      By Mark Wembridge With the slowdown in the developed world hitting healthcare spending,  pharmaceuticals companies are...

    35. October 31, 2011

      Sustainability lessons from the boardroom

      By Sarah Murray In one of his finance and sustainability classes at Columbia Business School, Bruce Usher likes to talk...

    36. FT Alphaville

      October 27, 2011

      Snap news

      Breaking pre-market news on Thursday, - BoJ eases policy, boosts asset buying fund – statement. - Royal Dutch Shell Q3 CCS...

    37. October 12, 2011

      Design space: A smart cap for insulin pens

      Product: Timesulin “smart cap” Designed: In-house Territory: Worldwide About 366m people suffer from diabetes, and about 27...

    38. September 11, 2011

      Novo Nordisk

      The decision to build a grandiose new corporate headquarters is too often an indicator that crisis is ahead; look at Time...

    Search for Novo Nordisk AS and

    RELATED VIDEOS

    Videos from FT.com that closely match this topic

    1. Rising insulin sales boost growth at Danish pharma group...
      September 14, 2014

      Rising insulin sales boost growth at Danish pharma group

    2. Lex on Novo Nordisk's failure to win approval on insulin drug...
      February 11, 2013

      Lex on Novo Nordisk's failure to win approval on insuli...